Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Santyl Ointment for Diabetic Foot Ulcers
NCT01143714Phase 4Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Jun 2010
- Primary completion
- Apr 2012
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of collagenase clostridium histolyticum in diabetic foot ulcer (DFU) (2 arms), sponsored by Healthpoint Biotherapeutics. Primary endpoint: Change in Wound Area at 4 weeks. Started Jun 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01143714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143714.